SCHEMBL4887536

SCHEMBL4887536

O=C1C=CC(=O)N1CCS(=O)(=O)CCN1C(=O)C=CC1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 9/20 0.56
FAAH O00519 5/20 0.56
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
MAPT P10636 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
TP53 P04637 2/20 0.54
HSP90AA1 P07900 1/20 0.54
TLR9 Q9NR96 1/20 0.54
PKM P14618 1/20 0.54
HPGD P15428 1/20 0.54
XBP1 P17861 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
RECQL P46063 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
GPR35 Q9HC97 1/20 0.54
GPR55 Q9Y2T6 1/20 0.54
PTGS1 P23219 7/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17072492 0.83 MGLL (0.41) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL155453 0.81 MGLL (0.52) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL14678413 0.78 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL145737 0.78 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL4896911 0.76 MGLL (0.46) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL15809670 0.73 MGLL (0.60) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL331378 0.73 MGLL (0.88) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL155748 0.73 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL258626 0.70 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL818349 0.70 MGLL (1.00) MGLLFAAHALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632941-B1 RESIN COMPOSITION CUBICURE GMBH (AT) 2023-08-23 EP claimed
EP-3632941-B1 RESIN COMPOSITION CUBICURE GMBH (AT) 2023-08-23 EP disclosed
US-20210395420-A1 RESIN COMPOSITION CUBICURE GMBH (AT) 2021-12-23 US disclosed
US-8362276-B2 Reacting a vinyl sulfone compound with imide compound in presence of catalyst INKTEC CO., LTD. (KR) 2013-01-29 US disclosed
US-8362276-B2 Reacting a vinyl sulfone compound with imide compound in presence of catalyst INKTEC CO., LTD. (KR) 2013-01-29 US disclosed
US-8362276-B2 Reacting a vinyl sulfone compound with imide compound in presence of catalyst INKTEC CO., LTD. (KR) 2013-01-29 US disclosed
US-20080262243-A1 Beta-Sulfone Imides and Preparation Thereof INKTEC CO., LTD. (KR) 2008-10-23 US disclosed
US-20080262243-A1 Beta-Sulfone Imides and Preparation Thereof INKTEC CO., LTD. (KR) 2008-10-23 US disclosed
US-20080262243-A1 Beta-Sulfone Imides and Preparation Thereof INKTEC CO., LTD. (KR) 2008-10-23 US disclosed
WO-2006107175-A1 BETA-SULFONE IMIDES AND PREPARATION THEREOF INKTEC CO., LTD. (KR) 2006-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262243-A1 Beta-Sulfone Imides and Preparation Thereof STS, CBS, SI MGLL 4376/4885FAAH 2794/4885ALDH1A1 1700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.